about
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal ca...
Read More
1.92
-0.08
(-4.00%)
76,975
XNAS Volume
XNAS 11 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Mainz Biomed N.V. is on 17 Jul 2025 for the purpose of Mainz Biomed NV First Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Mainz Biomed N.V. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..